search
for
 About Bioline  All Journals  Testimonials  Membership  News


Neurology India
Medknow Publications on behalf of the Neurological Society of India
ISSN: 0028-3886 EISSN: 1998-4022
Vol. 52, Num. 2, 2004, pp. 270-270

Neurology India, Vol. 52, No. 2, April-June, 2004, pp. 270

Letter To Editor

Differentiating paralytic rabies from post antirabies vaccine polyradiculoneuropathy

Neurology Unit, Department of Neurological Sciences, Christian Medical College Hospital, Vellore, Tamilnadu - 632004

Correspondence Address:Neurology Unit, Department of Neurological Sciences, Christian Medical College Hospital, Vellore, Tamilnadu - 632004
drsudhirkumar@yahoo.com

Code Number: ni04085

Sir,
The recent report of flaccid paralysis following anti-rabies vaccine (ARV) was interesting, where Behari et al describe the diagnostic dilemma in a patient presenting with flaccid paralysis following administration of ARV.[1] They mention that measurement of rabies antibody titer in the serum and cerebrospinal fluid could help in differentiating paralytic rabies from post-ARV polyradiculoneuropathy (Guillain-Barre syndrome, GBS). However, I would like to make certain observations.

Firstly, there are several features that could be useful in differentiating paralytic rabies from polyradiculoneuropathy, which could be summarized as follows:
1. History of dog bite: In a person who has not been bitten by a dog (as in the case reported by Behari et al), there is virtually no possibility of rabies and the diagnosis of GBS is straightforward.
2. Incubation period: The mean incubation period in paralytic rabies is 49 days,[2] as compared to 14 days in case of post-ARV neurological syndromes.[3]
3. Clinical involvement: Sphincter disturbances and sensory symptoms (in addition to ascending flaccid paralysis) are common in paralytic rabies,[4] which is not the case with post-ARV polyradiculoneuropathy. This could be explained on the basis of direct involvement of brainstem and spinal cord by rabies virus, proven by autopsy studies.[2]
4. Disease progression: Paralytic rabies progresses rapidly with early respiratory paralysis and death ensues within 7-11 days of symptom onset in all cases.[2] On the other hand, post-ARV polyradiculoneuropathy has a better outcome with conservative management[5] or immunotherapy and the mortality is less than 10%.[3]
5. Magnetic resonance imaging (MRI): MRI of the brain in paralytic rabies shows exclusive involvement of the gray matter including the basal ganglia, thalami, pontine and midbrain nuclei. This is in contrast to the predominant white matter involvement in post-vaccinial acute disseminated encephalomyelitis.[6] Moreover, in polyradiculoneuropathy; MRI is usually normal (as in the case reported by Behari et al).

Secondly, Behari et al treated their patient with steroids. However, significantly better therapeutic results have earlier been shown with cyclophosphamide as compared to steroids.[3] Moreover, patients treated with steroids have a higher incidence of relapse of GBS.[7] Plasmapheresis or intravenous immunoglobulins are better options for treatment of these patients.

References

1.Srivastava AK, Sardana V, Prasad K, Behari M. Diagnostic dilemma in flaccid paralysis following anti-rabies vaccine. Neurol India 2004;52:132-3.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Chopra JS, Banerjee AK, Murthy JM, Pal SR. Paralytic rabies: A clinico-pathological study. Brain 1980;103:789-802.  Back to cited text no. 2  [PUBMED]  
3.Swamy HS, Shankar SK, Chandra PS, Aroor SR, Krishna AS, Perumal VG. Neurological complications due to beta-propiolactone (BPL)-inactivated antirabies vaccination. Clinical, electrophysiological and therapeutic aspects. J Neurol Sci 1984;63:111-28.  Back to cited text no. 3  [PUBMED]  
4.Warrell DA. The clinical picture of rabies in man. Trans R Soc Trop Med Hyg 1976;70:188-95.  Back to cited text no. 4  [PUBMED]  
5.Arega D, Zenebe G. Peripheral neuropathy following administration of nerve tissue antirabies vaccine. Ethiop Med J 1999;37:269-73.  Back to cited text no. 5  [PUBMED]  
6.Mani J, Reddy BC, Borgohain R, Sitajayalakshmi S, Sundaram C, Mohandas S. Magnetic resonance imaging in rabies. Postgrad Med J 2003;79:352-4.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]
7.Dias-Tosta E, Brasil JP, Figueiredo MA. The use of corticosteroids in Guillain-Barre syndrome: study of 51 cases. Arq Neuropsiquiatr. 1986;44:117-24.  Back to cited text no. 7  [PUBMED]  

Copyright 2004 - Neurology India

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil